Perspective · 10 Sep 2026
Conference abstractPublished 21 Nov 2019
Angioedema with normal C1 inhibitor
KininX, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The emergence of clinical Angioedema (AE) is subsequent to Bradykinin (BK) production, with AE attacks resulting from a local endothelial permeability in the affected tissue. Kallikrein-Kinin System (KKS) and BK generation mediate this process. AE with normal C1Inhibitor (C1Inh) is difficult to diagnose. It is known to be unresponsive to treatment with antihistamines, corticosteroids, and epinephrine. AE with normal C1Inh is divided between patients with a known F12 mutation and recently with plasminogen or angiopoietin mutations and those with unknown origin. However, when the patient presents with an acute crisis, the biological profile is of great support for the decision of treatment and follow-up. Here we describe four patients admitted at the acute phase of angioedema in emergency department: abdominal cramps, respiratory distress, AE of the eyelids, tongue and lips. The diagnosis was often delayed. Despite the fact that one of the patients needed tracheal intubation in the past, he suffered from recurrent AE, without diagnosis, for the last 25 years. We believe that KKS biological workup is helpful. Three samples were harvested at different times during the attack and investigated. C1 Inhibitor (C1Inh) function, spontaneous amidase activity, kinin measurement and kininogen cleavage were analyzed as described previously. The results demonstrate that KKS activation and subsequently BK production are the key actors of these attacks, without decrease of C1Inh function. They also demonstrated a very important increased kinin forming process with increased spontaneous amidase activity in line with kininogen (HK) cleavage. In addition, the administration C1Inh concentrate results in clinical improvement. The symptomatology of angioedema is subsequent to the enzymatic activity responsible for kinin production. Kinetics of biological events demonstrates KKS activation and BK production. Laboratory confirmation using KKS biological parameters seems to be helpful for diagnosis and patients management.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Arije Ghannam”

